1. Home
  2. KULR vs RANI Comparison

KULR vs RANI Comparison

Compare KULR & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KULR Technology Group Inc.

KULR

KULR Technology Group Inc.

HOLD

Current Price

$2.43

Market Cap

116.6M

Sector

Technology

ML Signal

HOLD

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$0.78

Market Cap

106.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KULR
RANI
Founded
2013
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
116.6M
106.9M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
KULR
RANI
Price
$2.43
$0.78
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.50
AVG Volume (30 Days)
613.6K
482.4K
Earning Date
05-15-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.14
EPS
N/A
N/A
Revenue
$1,274,028.00
$1,633,000.00
Revenue This Year
$123.93
$274.77
Revenue Next Year
$63.38
$79.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
58.85
52 Week Low
$1.94
$0.45
52 Week High
$6.00
$3.87

Technical Indicators

Market Signals
Indicator
KULR
RANI
Relative Strength Index (RSI) 45.52 43.78
Support Level $2.30 $0.73
Resistance Level $3.15 $0.83
Average True Range (ATR) 0.10 0.05
MACD 0.02 -0.01
Stochastic Oscillator 53.85 24.61

Price Performance

Historical Comparison
KULR
RANI

About KULR KULR Technology Group Inc.

KULR Technology Group Inc develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components. The company is focused on targeting the following applications: electric vehicles and autonomous driving systems, artificial intelligence and Cloud computing, energy storage, 5G communication technologies, and other consumer and industrial devices. The Company operated two segments -EMP and Mining of Digital Assets.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: